We aim to transform how miRNAs are detected, providing simpler tools for health care and drug development professionals.
DestiNA Genomics has raised $2.6M in total funding. The most recent round was Grant. The last funding was announced in November 2025.
DestiNA Genomics's investors include European Innovation Council, Old College Capital, Vitro Group, Scottish Investment Bank.
DestiNA Genomics is headquartered in Edinburgh, United Kingdom.
We aim to transform how miRNAs are detected, providing simpler tools for health care and drug development professionals.
DestiNA Genomics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"DestiNA Genomics — Funding & Investors." VCBacked, November 27, 2025, https://www.vcbacked.co/company/destina-genomics. Accessed July 19, 2026.
VCBacked. (2025). DestiNA Genomics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/destina-genomics
{{cite web |title=DestiNA Genomics — Funding & Investors |url=https://www.vcbacked.co/company/destina-genomics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated